More on CD19-CAR T Cells in Systemic Lupus Erythematosus
More on CD19-CAR T Cells in Systemic Lupus Erythematosus
About this item
Full title
Author / Creator
Publisher
Boston: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
Mougiakakos et al. (Aug. 5 issue)
1
highlight the potential of CD19-directed chimeric antigen receptor (CAR) T-cell therapy in refractory systemic lupus erythematosus (SLE). Although the observed decrease in disease activity and anti–double-stranded DNA (dsDNA) antibody levels may be attributable to CAR-dependent depletion o...
Alternative Titles
Full title
More on CD19-CAR T Cells in Systemic Lupus Erythematosus
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2593604543
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2593604543
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMc2114593
